Memento Medicines
Boston, US · Founded 2025 · Delaware corporation · 5 known investors
Find your way into Memento Medicines
Sign up to see every warm intro you have to Memento Medicines
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Memento Medicines team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Privately-held biotech company developing biologic therapies for retinal diseases
Founders & leadership
Board


Investors · 5
How we know: Avego BioScience Capital's portfolio page · offering press articles · funding news · Not right? Tell us
How we know: RA Capital's portfolio page · board seat on SEC Form D · offering press articles · funding news · Not right? Tell us
How we know: Sanofi Ventures's portfolio page · a partner's Signal profile · offering press articles · funding news · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · offering press articles · funding news · Not right? Tell us
How we know: offering press articles · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$38M disclosed across 1 round · 2026
▶$38MraisedJun 2026 · 7 investors · BiotechnologyRule 506(b)
- Zach ScheinerDirector
- William Daley BonificioExecutive Officer, Promoter
- Megan KrenchDirector
- Stephen Basil ThomasExecutive Officer, Promoter
- Dmitrij HristodorovDirector
- Naveen Manu DaryaniExecutive Officer, Director, Promoter
- Vishal KapoorDirector
- Offering amount
- $93M
- Amount sold
- $38M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Memento Medicines do?
- Privately-held biotech company developing biologic therapies for retinal diseases
- Who are Memento Medicines's investors?
- Memento Medicines's investors include Avego BioScience Capital, RA Capital, Sanofi Ventures, Forbion, Samsara BioCapital.
- How much funding has Memento Medicines raised?
- Memento Medicines has disclosed $38M raised across 1 round.
- Where is Memento Medicines headquartered?
- Memento Medicines is headquartered in Boston, US.


